Obesity
Also known as: Morbid Obesity, Clinical Obesity
Obesity is a complex, chronic medical condition characterized by excessive body fat accumulation that presents a risk to health, typically defined as a body mass index (BMI) of 30 or higher. It significantly increases the risk of numerous diseases including type 2 diabetes, heart disease, stroke, certain cancers, and sleep apnea. Obesity results from a combination of genetic, behavioral, environmental, and metabolic factors.
Last updated October 31, 2026
Understanding Obesity
Obesity is a chronic disease in which the body carries enough excess fat to damage health, not simply a number on a scale. Doctors still screen for it with body mass index (BMI of 30 or above), but BMI cannot tell muscle from fat or see where fat sits, so waist circumference and a person's actual health problems matter more. A 2025 Lancet Diabetes and Endocrinology commission proposed splitting the diagnosis into 'preclinical obesity' (excess fat without organ dysfunction yet) and 'clinical obesity' (excess fat that is already impairing organs, such as fatty liver, sleep apnoea, knee osteoarthritis or type 2 diabetes). That distinction matters because it separates people who need prevention and monitoring from people who need active medical treatment now.
Fat tissue is not inert storage; it is an endocrine organ. As fat cells enlarge they leak inflammatory signals, become less responsive to insulin and distort the hormones that regulate appetite. The deeper problem is that the brain defends body weight. When a person loses weight by eating less, levels of the hunger hormone ghrelin rise and satiety hormones such as leptin, PYY and GLP-1 fall, and in one well-known Australian study those changes were still present a full year after a 10 percent weight loss. Resting metabolism also drops more than the lost tissue alone would predict. This is why weight loss feels like pushing against a spring and why regain is the norm rather than a personal failure.
Left alone, obesity tends to progress, pulling type 2 diabetes, high blood pressure, fatty liver, sleep apnoea and joint damage along with it. Conventional care starts with structured diet, activity and behaviour programmes, which realistically produce 3 to 7 percent weight loss over a year and still cut diabetes risk substantially. Medication changed the picture: in the STEP 1 trial, weekly semaglutide 2.4 mg produced an average 14.9 percent loss at 68 weeks versus 2.4 percent with placebo, and in SURMOUNT-1 tirzepatide 15 mg produced about 21 percent at 72 weeks. The SELECT trial then showed semaglutide cut major cardiovascular events by 20 percent in people with obesity and heart disease. Older drugs give roughly 3 to 9 percent. Bariatric surgery produces 25 to 30 percent total body weight loss, puts type 2 diabetes into remission in most patients, and lowers long-term mortality. Nausea, cost and regain after stopping drugs are the honest trade-offs.
Natural products sit firmly in the adjunct category here, and it is important to be plain about scale. The best-studied supplements, taken for 12 weeks alongside a calorie deficit, add roughly 1 to 3 kilograms of extra loss on average: green tea extract about 1 kg in a Cochrane review, berberine about 2 kg in meta-analyses of mostly metabolic-syndrome patients, psyllium and glucomannan a similar amount when they work at all. That is real but small next to a 15 kg loss from a GLP-1 drug. None of them has Strong evidence for obesity itself, so the list below starts at Moderate. The more serious issue is safety: the US FDA has issued hundreds of warnings about 'fat burners' and 'natural' slimming products that were secretly spiked with sibutramine, phenolphthalein, fluoxetine or the industrial poison DNP. If a weight loss product works dramatically, assume it is adulterated.
The thing most people get wrong is treating obesity as a willpower problem with a willpower solution. Hunger after weight loss is a hormonal signal, not a character flaw, and the people who keep weight off in long-term registries do so with permanent structural habits (daily weighing, high activity, consistent breakfast, limited eating out) rather than bursts of discipline. The goal that actually improves health is a sustained 5 to 10 percent loss, which lowers blood pressure, triglycerides, HbA1c and liver fat measurably, not reaching a 'normal' BMI. Judging success by that standard makes the whole project far more achievable.
At a Glance
- Common symptoms
- BMI of 30 or greater, Excess body fat, particularly around the abdomen, Shortness of breath with minimal exertion
- Main treatments
- Dietary modification with caloric deficit and nutritional counseling, Regular physical activity (150+ minutes of moderate exercise per week), Behavioral therapy and cognitive-behavioral strategies
- Category
- Metabolic · Over 40% of US adults; approximately 650 million adults worldwide
- See a doctor if
- BMI of 30 or higher, or 25+ with obesity-related health issues
Symptoms
Causes
- Chronic caloric surplus (energy intake exceeding expenditure)
- Genetic factors affecting appetite regulation and fat storage
- Sedentary lifestyle and reduced physical activity
- Hormonal imbalances (hypothyroidism, Cushing syndrome, PCOS)
- Certain medications (corticosteroids, antipsychotics, some antidepressants)
- Socioeconomic factors limiting access to healthy food
Risk Factors
- Family history of obesity
- Sedentary occupation and lifestyle
- High-calorie, ultra-processed food diet
- Lack of sleep
- Psychological stress and emotional eating
- Low socioeconomic status
Diagnosis
- BMI calculation (weight in kg divided by height in meters squared)
- Waist circumference measurement (>40 inches in men, >35 inches in women indicates central obesity)
- Blood tests (fasting glucose, HbA1c, lipid panel, thyroid function)
- Blood pressure and cardiovascular risk assessment
- Screening for obesity-related complications
Treatment
- Dietary modification with caloric deficit and nutritional counseling
- Regular physical activity (150+ minutes of moderate exercise per week)
- Behavioral therapy and cognitive-behavioral strategies
- Anti-obesity medications (semaglutide, tirzepatide, phentermine-topiramate, orlistat)
- Bariatric surgery (gastric bypass, sleeve gastrectomy) for BMI ≥40 or ≥35 with comorbidities
- Treatment of underlying hormonal or metabolic conditions
Natural remedies for obesity: what the evidence says
Ranked by the strength of human evidence for obesity specifically. These sit alongside medical care, not in place of it.
Green Tea Extract (EGCG)
Moderate evidenceA 2012 Cochrane review of 14 trials in overweight or obese adults found green tea preparations produced a small, statistically non-significant extra weight loss of roughly 0.2 to 3.5 kg over about 12 weeks, with effects strongest in Japanese trials and weakest outside Asia. Earlier meta-analysis estimated about 1.3 kg. Benefit depends on caffeine and appears to fade in heavy coffee drinkers.
- Studied dose
- Standardised extract providing 250 to 500 mg EGCG daily, taken with food; not on an empty stomach.
- Cautions
- Concentrated extracts (not brewed tea) have caused rare liver injury, with the FDA and EFSA flagging doses above about 800 mg EGCG per day; stop if you develop dark urine or jaundice. Caffeine content can raise blood pressure and interact with stimulant weight loss drugs; avoid in pregnancy and in people with liver disease.
Berberine
Moderate evidenceMeta-analyses of around 12 randomised trials, mostly in people with metabolic syndrome, type 2 diabetes or fatty liver, found berberine reduced body weight by roughly 2 kg and BMI by about 0.5 over 8 to 16 weeks compared with placebo, with larger effects on waist circumference and triglycerides than on weight itself. Trials in people with obesity but no metabolic disease are few and small, so the 'natural Ozempic' label is marketing, not evidence.
- Studied dose
- 500 mg two or three times daily with meals (1,000 to 1,500 mg per day) for 8 to 16 weeks.
- Cautions
- Berberine inhibits CYP3A4 and CYP2D6 and can raise levels of metformin, statins, ciclosporin and some antidepressants; it also adds to the glucose-lowering effect of diabetes drugs. Contraindicated in pregnancy, breastfeeding and newborns (kernicterus risk); commonly causes constipation or diarrhoea.
Psyllium Husk
Moderate evidenceA 2023 meta-analysis of randomised trials in adults with overweight or obesity found psyllium taken before meals produced about 2 kg more weight loss and roughly 2 cm more waist reduction than control over 12 weeks or longer, with the effect appearing mainly in people with overweight or obesity rather than normal-weight participants. Psyllium also reliably lowers LDL cholesterol by about 6 percent and improves fasting glucose, which matters for the conditions that travel with obesity.
- Studied dose
- 5 to 10 g of psyllium husk powder in at least 250 ml of water, taken 15 to 30 minutes before meals, two to three times daily.
- Cautions
- Must be taken with plenty of water; it can obstruct the gut if swallowed dry or by people with strictures or swallowing problems. Separate from medications by at least 2 hours because it can reduce absorption of lithium, carbamazepine, digoxin and levothyroxine; may need insulin or sulfonylurea dose adjustment in diabetes.
Glucomannan (Konjac Fibre)
Moderate evidenceResults are split. The European Food Safety Authority accepted a weight loss claim for 3 g per day with an energy-restricted diet based on trials showing roughly 1 to 2 kg extra loss over 5 to 8 weeks, but a 2014 systematic review of 9 randomised trials found no statistically significant effect overall, and a well-run 2013 trial of 1.33 g three times daily for 8 weeks found no difference from placebo. It is a reasonable satiety aid, not a reliable weight loss agent.
- Studied dose
- 1 g with 1 to 2 glasses of water, 30 to 60 minutes before each of three meals (3 g per day).
- Cautions
- Tablets have caused oesophageal and bowel obstruction when swallowed without enough water; use powder or capsules with a full glass of water. It can slow absorption of oral drugs taken at the same time and lowers blood glucose, so people on insulin or sulfonylureas should monitor more closely.
Probiotics (Lactobacillus strains)
Moderate evidenceMeta-analyses of roughly 15 to 20 randomised trials find probiotics reduce body weight by about 0.5 to 0.6 kg and BMI by about 0.3 over 8 to 12 weeks, which is measurable but not clinically meaningful on its own. The best single result came from a Japanese trial of Lactobacillus gasseri SBT2055 in fermented milk, where 12 weeks reduced visceral fat area by about 4.6 percent versus control. Strain-specific effects mean one product's results do not transfer to another.
- Studied dose
- Strain-specific; trials used 10^9 to 10^10 CFU daily of L. gasseri, L. rhamnosus or multi-strain blends for 8 to 12 weeks.
- Cautions
- Generally safe, but avoid in people with central venous catheters, severe pancreatitis, or significant immunosuppression (including after bariatric surgery with complications) because of rare cases of bacteraemia. Bloating in the first week is common.
Chromium Picolinate
Moderate evidenceA 2013 Cochrane review of 9 trials in 622 overweight or obese adults found chromium picolinate at 200 to 1,000 mcg per day produced about 0.5 kg more weight loss than placebo over 12 to 16 weeks, with no clear dose-response and low-quality evidence. The authors judged the effect of doubtful clinical relevance. Trials in binge eating and carbohydrate cravings are small and mixed.
- Studied dose
- 200 to 400 mcg chromium picolinate daily for 12 weeks; higher doses added nothing in trials.
- Cautions
- Rare reports of kidney and liver injury at doses above 1,000 mcg; avoid in kidney disease. Chromium may enhance insulin and sulfonylurea effects, and taking it with levothyroxine reduces thyroid hormone absorption, so separate doses by several hours.
Capsaicin and Capsinoids
Preliminary evidenceCapsaicin and its non-pungent cousins (capsinoids) activate TRPV1 receptors and brown fat, raising energy expenditure by roughly 50 kcal per day and reducing appetite modestly in short feeding studies. A meta-analysis of capsinoid trials found about 0.6 kg extra loss over 12 weeks at 6 mg per day. The effect is real in a lab and too small to notice on a scale without other changes.
- Studied dose
- 2 to 6 mg capsinoids or 2 to 10 mg capsaicin daily with meals, or simply regular chilli in food.
- Cautions
- Causes heartburn and stomach upset, worsens reflux and gastritis, and can irritate the gut after bariatric surgery. Theoretically increases bleeding tendency with anticoagulants at high doses; stop 2 weeks before surgery.
What matters day to day
- Aim for 5 to 7 percent weight loss, not a 'normal' BMI: in the Diabetes Prevention Program, losing 7 percent of body weight with 150 minutes of weekly activity cut progression to type 2 diabetes by 58 percent over 3 years, outperforming metformin.
- Cut ultra-processed food rather than counting a single nutrient: in a tightly controlled NIH feeding study, people allowed to eat freely from an ultra-processed menu ate about 500 kcal more per day and gained 0.9 kg in 2 weeks compared with a matched minimally processed diet.
- Protect sleep: adults sleeping under 6 hours have around 50 percent higher odds of obesity, and a 2022 trial that extended sleep by about 1.2 hours a night cut calorie intake by roughly 270 kcal per day without any dieting.
- Lift weights while losing weight, especially on a GLP-1 drug: up to 25 to 40 percent of weight lost by diet or medication alone is lean tissue, and 2 to 3 resistance sessions a week with adequate protein (about 1.2 to 1.6 g per kg) preserves most of it.
- Weigh yourself daily or weekly: self-weighing is one of the most consistent habits among people in the National Weight Control Registry who have kept off an average of 30 kg for more than 5 years.
Prevention
- Maintain a balanced, nutrient-dense diet
- Engage in at least 150 minutes of moderate physical activity weekly
- Limit consumption of sugar-sweetened beverages and ultra-processed foods
- Get 7–9 hours of quality sleep per night
- Monitor weight regularly and address small gains early
When to See a Doctor
- BMI of 30 or higher, or 25+ with obesity-related health issues
- Difficulty losing weight despite diet and exercise efforts
- Symptoms of obesity-related conditions (joint pain, sleep apnea, diabetes symptoms)
- Interest in medical or surgical weight management options
Frequently Asked Questions
References
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (2021)
- Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (2022)
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine (2023)
- Knowler WC, Barrett-Connor E, Fowler SE, et al. (Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine (2002)
- Sumithran P, Prendergast LA, Delbridge E, et al.. Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine (2011)
- Hall KD, Ayuketah A, Brychta R, et al.. Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial. Cell Metabolism (2019)
- Jurgens TM, Whelan AM, Killian L, et al.. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database of Systematic Reviews (2012)
- Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Journal of the American College of Nutrition (2014)
- Rubino F, Cummings DE, Eckel RH, et al.. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes and Endocrinology (2025)
- US Food and Drug Administration. Tainted Weight Loss Products (2024)View source
Related Conditions
Evidence-graded guides
Lab tests that relate to obesity
Related from the Supplement Library
Berberine
StrongCompound · Blood sugar regulation comparable to metformin (AMPK activation)
Chromium
ModerateMineral · Blood sugar regulation and insulin sensitivity
Omega-3 (EPA/DHA)
StrongFatty Acid · Cardiovascular health (TG reduction, anti-arrhythmic)
Green Tea Extract (EGCG)
StrongCompound · Antioxidant protection (EGCG catechins)
Probiotics (Lactobacillus)
StrongProbiotic · Gut microbiome balance and diversity
These supplements have been studied in relation to Obesity. Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Fibermaxxing: How to Increase Fiber Without Wrecking Your Gut
Fiber is one of the best-supported nutrition levers for gut, metabolic, and cardiovascular health. The hard part is increasing it slowly enough to avoid bloating. Here is the evidence, the ramp-up protocol, and the mistakes to avoid.
Vitamin D in Winter: D3 vs D2, How Much to Take, and When
In winter, skin makes little vitamin D across much of the north. What the research says about D3 vs D2, how much to take, timing and safe upper limits.
NMN and NAD+: Can These Longevity Supplements Actually Slow Aging?
NMN and NAD+ supplements are the hottest longevity trend of 2026. Here is what the latest human clinical trials actually show — and how AI-powered health tools are helping people build smarter, more personalized anti-aging protocols.
Have questions about Obesity?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.